Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

315 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk prediction model for cisplatin-induced acute kidney injury in patients with head and neck cancer receiving chemoradiotherapy: A re-analysis of a phase II/III JCOG1008 trial.
Imamura Y, Kiyota N, Tahara M, Kodaira T, Hayashi R, Nishino H, Asada Y, Mitani H, Iwae S, Nishio N, Onozawa Y, Hanai N, Ohkoshi A, Hara H, Monden N, Nagaoka M, Minami S, Kitabayashi R, Sasaki K, Homma A; Head, Neck Cancer Study Group of the Japan Clinical Oncology Group (JCOG-HNCSG). Imamura Y, et al. Among authors: kodaira t. Oral Oncol. 2024 Jul;154:106868. doi: 10.1016/j.oraloncology.2024.106868. Epub 2024 May 30. Oral Oncol. 2024. PMID: 38820889 Clinical Trial.
Impact of age for overall survival in head and neck sarcoma.
Suzuki H, Takano G, Tsukushi S, Ando M, Yatabe Y, Kodaira T, Nishikawa D, Beppu S, Hasegawa Y, Hanai N. Suzuki H, et al. Among authors: kodaira t. Medicine (Baltimore). 2023 Feb 17;102(7):e32966. doi: 10.1097/MD.0000000000032966. Medicine (Baltimore). 2023. PMID: 36800630 Free PMC article.
Summary of Japanese clinical practice guidelines for head and neck cancer - 2022 update edited by the Japan society for head and neck cancer.
Homma A, Ando M, Hanai N, Harada H, Honma Y, Kanda T, Kano S, Kawakita D, Kiyota N, Kizawa Y, Nakagawa M, Ogawa T, Shinomiya H, Shinozaki T, Suzuki M, Tsuji T, Yasuda K, Zenda S, Kodaira T, Kirita T, Nibu KI. Homma A, et al. Among authors: kodaira t. Auris Nasus Larynx. 2024 Feb;51(1):174-188. doi: 10.1016/j.anl.2023.07.003. Epub 2023 Jul 21. Auris Nasus Larynx. 2024. PMID: 37482431 Review.
Novel approach of prophylactic radiation to reduce toxicities comparing 2-step40 with 56-Gy simultaneous integrated boost intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the head and neck, an intergroup phase III trial (JCOG1912, NEW BRIDGE).
Yokota T, Zenda S, Kodaira T, Kiyota N, Fujimoto Y, Wasano K, Takahashi R, Mizowaki T, Homma A, Sasaki K, Machida R, Sekino Y, Fukuda H; Japan Clinical Oncology Group Radiation Therapy Study Group; Japan Clinical Oncology Group Head and Neck Cancer Study Group. Yokota T, et al. Among authors: kodaira t. BMC Cancer. 2023 Nov 6;23(1):1068. doi: 10.1186/s12885-023-11503-z. BMC Cancer. 2023. PMID: 37932681 Free PMC article. Clinical Trial.
Safety and Efficacy of Gemcitabine Plus Cisplatin Against Recurrent/Metastatic Nasopharyngeal Carcinoma: A Retrospective Study.
Kodama H, Kadowaki S, Nakazawa T, Matsubara Y, Narita Y, Honda K, Masuishi T, Taniguchi H, Ando M, Koide Y, Tachibana H, Kodaira T, Sawabe M, Terada H, Beppu S, Nishikawa D, Suzuki H, Hanai N, Muro K. Kodama H, et al. Among authors: kodaira t. Anticancer Res. 2024 Mar;44(3):1227-1232. doi: 10.21873/anticanres.16918. Anticancer Res. 2024. PMID: 38423663
Definitive S-1/mitomycin-C chemoradiotherapy for stage II/III anal canal squamous cell carcinoma: a phase I/II dose-finding and single-arm confirmatory study (JCOG0903).
Ito Y, Hamaguchi T, Takashima A, Mizusawa J, Shimada Y, Shiozawa M, Mizoguchi N, Kodaira T, Komori K, Ohue M, Konishi K, Teraishi F, Kinouchi M, Murata K, Fujita F, Watanabe M, Iinuma G, Ishida F, Saida Y, Matsuda T, Katayama H, Fukuda H, Kanemitsu Y; Colorectal Cancer Study Group of the Japan Clinical Oncology Group. Ito Y, et al. Among authors: kodaira t. Int J Clin Oncol. 2023 Aug;28(8):1063-1072. doi: 10.1007/s10147-023-02361-7. Epub 2023 Jun 7. Int J Clin Oncol. 2023. PMID: 37286878 Clinical Trial.
Long-Term Follow-up of a Randomized Controlled Trial on Accelerated Radiation Therapy Versus Standard Fractionated Radiation Therapy for Early Glottic Cancer (JCOG0701A3).
Kodaira T, Kagami Y, Machida R, Shikama N, Sekino Y, Ito Y, Ishikura S, Saito Y, Matsumoto Y, Konishi K, Murakami N, Akimoto T, Fukushima Y, Toshiyasu T, Katano A, Nagata Y, Ogawa H, Uno T, Hamamoto Y, Nishimura Y, Mizowaki T. Kodaira T, et al. Int J Radiat Oncol Biol Phys. 2023 Dec 1;117(5):1118-1124. doi: 10.1016/j.ijrobp.2023.06.251. Epub 2023 Jul 5. Int J Radiat Oncol Biol Phys. 2023. PMID: 37414261 Free article. Clinical Trial.
Survival Outcome Superiority of Total Pharyngolaryngectomy Compared with Chemoradiotherapy for T4aM0 Hypopharyngeal Squamous Cell Carcinoma: A Nationwide Database Study of Japan.
Omura G, Eguchi K, Yoshimoto S, Honma Y, Fushimi C, Sakai T, Matsumoto Y, Sakai A, Kitayama M, Kawakita D, Kirita T, Kodaira T, Nakamizo M, Nibu KI. Omura G, et al. Among authors: kodaira t. Ann Surg Oncol. 2024 Nov;31(12):8206-8213. doi: 10.1245/s10434-024-15994-3. Epub 2024 Aug 12. Ann Surg Oncol. 2024. PMID: 39133449
In Reply to Yamazaki et al.
Kodaira T, Kagami Y, Shikama N. Kodaira T, et al. Int J Radiat Oncol Biol Phys. 2024 Mar 1;118(3):865-866. doi: 10.1016/j.ijrobp.2023.11.004. Int J Radiat Oncol Biol Phys. 2024. PMID: 38340771 No abstract available.
315 results